Back Source: > 29 December 2009 (E-Business) Cephalon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile--Aarkstore Enterprise New report "Cephalon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" available through Aarkstore.com  Cephalon, Inc. (Cephalon), a biopharmaceutical company is engaged in the research, development and marketing of innovative therapeutic products. The company develops products for the treatment of oncology, pain, central nervous disorders and addiction which include eight proprietary products in the United States, along with more than 30 products internationally. The company operates through its wholly owned subsidiaries worldwide. The product portfolio of the company includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, oral transmucosal fentanyl citrate and cyclobenzaprine hydrochloride extended release capsules. Cephalon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals. Scope - Provides key company information for business intelligence needs - Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement. For more information please visit : http://www.aarkstore.com/reports/Cephalon-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-21722.html  Visit